pregnadienes - CISMeF

Preferred Label : pregnadienes;

MeSH definition : Pregnane derivatives containing two double bonds anywhere within the ring structures.;

Is substance : O;

Détails

Origin ID

D011245;

UMLS CUI

C0032959;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Record concept(s)
- pregnadienes [MeSH concept]
Related MeSH Supplementary Concept(s)
- 12-hydroxy-3-oxo-1,4-pregnadiene-20-carboxylic acid [MeSH Supplementary Concept]
- 17-benzoyloxy-11-hydroxy-3,20-dioxo-1,4-pregnadien-21-al hemiacetal [MeSH Supplementary Concept]
- 20-(N,N-dimethylamino)-3--(2-methyl-2-butenamido)pregna-5,14-dien-4-one [MeSH Supplementary Concept]
- 20-carboxy-1,4-pregnadien-3-one [MeSH Supplementary Concept]
- 20-hydroximino-4,16-pregnadien-3-one [MeSH Supplementary Concept]
- 20-succinamylpregna-1,4-dien-3-one [MeSH Supplementary Concept]
- 21-hydroxypregna-1,4-diene-3,11,20-trione [MeSH Supplementary Concept]
- 3 alpha-hydroxy-5 alpha-pregna-9(11),16-diene-20-one [MeSH Supplementary Concept]
- 3-hydroxy-21-(1H-1,2,4-triazol-1-yl)pregna-5,16-dien-20-one [MeSH Supplementary Concept]
- 3-hydroxy-21-(1H-imidazol-1-yl)pregna-5,16-dien-20-one [MeSH Supplementary Concept]
- 3-hydroxy-5,16-pregnadien-20-one [MeSH Supplementary Concept]
- 3-hydroxy-5,7-pregnadien-20-one [MeSH Supplementary Concept]
- 4,16-pregnadiene-3,20-dione-20-oxime acetate [MeSH Supplementary Concept]
- 5 alpha-pregna-1,20-diene-3-one [MeSH Supplementary Concept]
- 6 beta methoxy-9 beta,10 alpha-pregna-4,6-dien-3,20-dione [MeSH Supplementary Concept]
- GR 2-1159 [MeSH Supplementary Concept]
- N-butyl-N-methyl-11-(3'-hydroxy-21'-17'-carbolactone-19'-nor-17' -pregna-1',3',5'(10')-trien-7'-yl)-undecanamide [MeSH Supplementary Concept]
- SC 17599 [MeSH Supplementary Concept]
- domoprednate [MeSH Supplementary Concept]
- icometasone enbutate [MeSH Supplementary Concept]
- methyl 21-desoxy-21-chloro-11,17-dihydroxy-3,20-dioxo-1,4-pregnadiene-16-carboxylate [MeSH Supplementary Concept]
- methyl 21-desoxy-21-chloro-11-hydroxy-3,20-dioxo-1,4-pregnadiene-16-carboxylate [MeSH Supplementary Concept]
- nivazol [MeSH Supplementary Concept]
- oxyma [MeSH Supplementary Concept]
- pregna-1,4-dien-3-on-20-al [MeSH Supplementary Concept]
- pregna-4,20-diene-3,6-dione [MeSH Supplementary Concept]
- pregna-5,20-dien-3-O-alpha-fucopyranoside [MeSH Supplementary Concept]
- rimexolone [MeSH Supplementary Concept]
- ro 12-2503 [MeSH Supplementary Concept]
- ro 14-9012 [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients